Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Plasma macrophage migration inhibitor factor is elevated in response to myocardial ischemia

Fan F, Fang L, Moore XL, Xie X, Du XJ, White DA, O'Brien J, Thomson H, Wang J, Schneider HG, Ellims A, Barber TW, Dart AM

(2016), J Am Heart Assoc, 5(7),

Impact of high-sensitivity troponin I testing with sex-specific cutoffs on the diagnosis of acute myocardial infarction

Trambas C, Pickering JW, Than M, Bain C, Nie L, Paul E, Dart A, Broughton A, Schneider HG

(2016), Clin Chem, 62(6),

Should routine laboratories stop doing screening serum protein electrophoresis and replace it with screening immune-fixation electrophoresis? No quick fixes: Counterpoint

Smith JD, Raines G, Schneider HG

(2016), Clin Chem Lab Med, 54(6),

Taenia solium taeniasis and cysticercosis in Southeast Asia

Aung AK, Spelman DW

(2016), Am J Trop Med Hyg, 94(5),

Targeting plasma cells: are we any closer to a panacea for diseases of antibody-secreting cells?

Low M, Infantino S, Grigoriadis G, Tarlinton D

(2016), Immunol Rev, 270(1),

Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice

Lee EM, Yee D, Busfield SJ, McManus JF, Cummings N, Vairo G, Wei A, Ramshaw HS, Powell JA, Lopez AF, Lewis ID, McCall MN, Lock RB

(2015), Haematologica, 100(7), 914-26

Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study

Ravandi F, Ritchie EK, Sayar H, Lancet JE, Craig MD, Vey N, Strickland SA, Schiller GJ, Jabbour E, Erba HP, Pigneux A, Horst HA, Recher C, Klimek VM, Cortes J, Roboz GJ, Odenike O, Thomas X, Havelange V, Maertens J, Derigs HG, Heuser M, Damon L, Powell BL, Gaidano G, Carella AM, Wei A, Hogge D, Craig AR, Fox JA, Ward R, Smith JA, Acton G, Mehta C, Stuart RK, Kantarjian HM

(2015), Lancet Oncol, 16(9), 1025-36

Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia

Ling VY, Lee D, McQuilten Z, Avery S, Low M, Cody SH, Nguyen T, McLean C, Gorniak M, Wei A, Ting SB

(2015), Am J Hematol, 90(12), E219-20

Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran

Bouchard J, Ghannoum M, Bernier-Jean A, Williamson D, Kershaw G, Weatherburn C, Eris JM, Tran H, Patel JP, Roberts DM

(2015), Clin Toxicol, 53(3), 156-63

Treating pulmonary embolism in Pacific Asia with direct oral anticoagulants

Cohen A, Jeyaindran S, Kim JY, Park K, Sompradeekul S, Tambunan KL, Tran H, Tsai IC, Ward C, Wong R

(2015), Thromb Res, 136(2), 196-207

Heparin induced thrombocytopenia in critically ill: diagnostic dilemmas and management conundrums

Gupta S, Tiruvoipati R, Green C, Botha J, Tran H

(2015), World J Crit Care Med, 4(3), 202-12

Isolated iliac vein thrombosis in pregnancy

Keragala CB, Cummins KD, Goergen SK, Shipp D, Chunilal S

(2015), Intern Med J, 45(4), 460-1

Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia

Wei A, Tan P, Perruzza S, Govindaraj C, Fleming S, McManus J, Avery S, Patil S, Stevenson W, Plebanski M, Spencer A

(2015), Br J Haematol, 169(2), 199-210

Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation

Pham T, Patil S, Fleming S, Avery S, Walker P, Wei A, Curtis D, Stuart G, Klarica D, O'Brien M, Morris K, Das T, Bollard G, Muirhead J, Coutsouvelis J, Spencer A

(2015), Transfusion, 55(11), 2709-13

A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia

Kalff A, Khong T, Wall M, Gorniak M, Mithraprabhu S, Campbell LJ, Spencer A

(2015), Haematologica, 100(2), e60-2

Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma

Mithraprabhu S, Kalff A, Chow A, Khong T, Spencer A

(2015), Epigenetics, 9(11), 1511-20

The role of multiparametric flow cytometry in the detection of minimal residual disease in acute leukaemia

Lee D, Grigoriadis G, Westerman D

(2015), Pathology, 47(7), 609-21

The evolving role of the transfusion practitioner

Miller K, Akers C, Davis AK, Wood E, Hennessy C, Bielby L

(2015), Transfus Med Rev, 29(2), 138-44

Low levels of CD9 coincidental with a novel nonsense mutation in glycoprotein Ibβ in a patient with Bernard-Soulier syndrome

Qiao J, Davis AK, Morel-Kopp MC, Ward CM, Gardiner EE, Andrews RK

(2015), Ann Hematol, 94(12), 2069-71

How unique is pure erythroid leukaemia? A retrospective analysis of seven cases and review of the literature

Wong E, Ling V, Westerman D, Morgan S, Juneja S

(2015), J Clin Pathol, 68(4), 301-5

10 11 12 13 14